A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.
Condition(s):MigrainesLast Updated:July 31, 2007Completed
Hide Studies Not Open or Pending
Condition(s):MigrainesLast Updated:July 31, 2007Completed
Condition(s):Healthy; Obesity; PharmacokineticsLast Updated:July 3, 2012Terminated
Condition(s):Mania; Mixed ManiaLast Updated:December 6, 2007Completed
Condition(s):Traumatic Brain Injury (TBI); AlcoholismLast Updated:January 10, 2020Completed
Condition(s):Small Cell Lung CarcinomaLast Updated:February 12, 2015Completed
Condition(s):Bipolar DisorderLast Updated:November 16, 2007Completed
Condition(s):Scleroderma; Systemic SclerosisLast Updated:August 11, 2016Withdrawn
Condition(s):Epilepsy; Bipolar DisorderLast Updated:March 28, 2017Completed
Condition(s):Acute Myelogenous Leukaemia (AML); Myelodysplastic Syndrome (MDS)Last Updated:May 9, 2011Completed
Condition(s):Bipolar I Disorder, Manic or MixedLast Updated:March 19, 2007Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.